EMP 3 is upregulated in HER-2-positive breast cancer [43] and is associated with Myc proteins [44], and its knockdown has been shown to reduce cell proliferation and invasiveness in hepatocellular carcinoma [33]. The gene discussed is ERBB2; the disease is breast cancer.